题名

Naringenin mitigates antituberculosis drugs induced hepatic and renal injury in rats

DOI

10.1016/j.jtcme.2019.01.001

作者

Nisha Sahu;Gita Mishra;Hemeshwer Kumar Chandra;Satendra Kumar Nirala;Monika Bhadauria

关键词

Antituberculosis drugs ; Naringenin ; Hepato-renal injury ; Histopathology ; Antioxidant activity ; Oxidative stress

期刊名称

Journal of Traditional and Complementary Medicine

卷期/出版年月

10卷1期(2020 / 01 / 01)

页次

26 - 35

内容语文

英文

中文摘要

Tuberculosis is one of the deadly diseases, which can be well treated by antituberculosis drugs (ATDs) i.e. isoniazid, rifampicin, pyrazinamide and ethambutol. These drugs also lead to severe hepatic and renal injury. The present study was designed to investigate efficacy of naringenin against ATDs induced hepato-renal injury. Rats were administered with ATDs for 8 weeks (3 day/week) followed by naringenin at three different doses (10, 20 and 40 mg/kg) conjointly for 8 weeks (3 days/week) orally. Silymarin (50 mg/kg) was used as positive control in the study. Hepatic and renal injury was measured by increased level of serological parameters such as aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, bilirubin, urea, uric acid and creatinine. The toxic effect of ATDs was also indicated by significant increase in lipid peroxidation along with decline in GSH, catalase and superoxide dismutase activity in liver and kidney tissues. Treatment with naringenin encountered ATDs induced injury as evident by significant reversal of biochemical indices towards their respective control in a dose dependent manner. Histopathological observations also supported biochemical findings. Assessment of TNF-α indicated therapeutic efficacy of naringenin at molecular level. Thus, results of this study clearly showed that naringenin possess protective role against ATDs induced hepato-renal injury and to take naringenin supplementation as food may be worthwhile to reduce ATDs induced hepato-renal injury.

主题分类 醫藥衛生 > 中醫藥學
参考文献
  1. Jahromi, HK,Pourahmad, M,Abedi, HA,Jahromi, ZK(2018).Protective effects of salep against isoniazid liver toxicity in wistar rats.J Tradit Complement Med,8(1),239-243.
    連結:
  2. (2014).Pharmacology and Nutritional Intervention in the Treatment of Disease.InTech.
  3. (1984).Methods in Enzymology.Academic Press.
  4. Ali, ZY.(2012).Biochemical evaluation of some natural products against toxicity induced by anti-tubercular drugs in rats.Nucl Sci J.,5(10),69-80.
  5. Amić, D,Davidović-Amić, D,Bešlo, D,Trinajstić, N(2003).Structure-radical scavenging activity relationships of flavonoids.Croat Chem Acta,76(1),155-61.
  6. Arbex, MA,Varella, MD,Siqueira, HR,Mello, FA(2010).Antituberculosis drugs: drug interactions, adverse effects, and use in special situations-part 1: first-line drugs.J Bras Pneumol,36(5),626-640.
  7. Attri, S,Rana, SV,Vaiphei, K(2000).Isoniazid-and rifampicin-induced oxidative hepatic injury-protection by N-acetylcysteine.Hum Exp Toxicol,19(9),517-522.
  8. Avitsur, R,Hunzeker, J,Sheridan, JF(2006).Role of early stress in the individual differences in host response to viral infection.Brain Behav Immun,20(4),339-348.
  9. Bais, B,Saiju, P.(2014).Ameliorative effect of Leucas cephalotes extract on isoniazid and rifampicin induced hepatotoxicity.Asian Pac J Trop Biomed,4,633-648.
  10. Das, SK,Mukherjee, S,Vasudevan, DM(2008).Medicinal properties of milk thistle with special reference to silymarinn: an overview.Nat Product Radiance,7(2),182-192.
  11. Del Prete, A,Scalera, A,Iadevaia, MD(2012).Herbal products: benefits, limits, and applications in chronic liver disease.Evid Based Complement Alternat Med,2012,837939.
  12. Dong, Y,Huang, J,Lin, X(2014).Hepatoprotective effects of Yulangsan polysaccharide against isoniazid and rifampicin-induced liver injury in mice.J Ethnopharmacol,152(1),201-206.
  13. Hermenean, A,Ardelean, A,Stan, M(2013).Protective effects of naringenin on carbon tetrachloride-induced acute nephrotoxicity in mouse kidney.Chem Biol Interact,205(2),138-147.
  14. Hooper, DC,Morimoto, K,Bette, M,Weihe, E,Koprowski, H,Dietzschold, B(1998).Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system.J Virol,72(5),3711-3719.
  15. Hussain, T,Gupta, RK,Sweety, K(2012).Evaluation of antihepatotoxic potential of Solanum xanthocarpum fruit extract against antitubercular drugs induced hepatopathy in experimental rodents.Asian Pac J Trop Biomed,2(6),454-460.
  16. Jaswal, A,Sinha, N,Bhadauria, M,Shrivastava, S,Shukla, S(2013).Therapeutic potential of thymoquinone against anti-tuberculosis drugs induced liver damage.Environ Toxicol Pharmacol,36(3),779-786.
  17. Jayaraman, J,Jesudoss, VA,Menon, VP,Namasivayam, N(2012).Anti-inflammatory role of naringenin in rats with ethanol induced liver injury.Toxicol Mech Methods,22(7),568-576.
  18. Lim, R,Barker, G,Wall, CA,Lappas, M(2013).Dietary phytophenols curcumin, naringenin and apigenin reduce infection-induced inflammatory and contractile pathways in human placenta, foetal membranes and myometrium.Mol Hum Reprod,19(7),451-462.
  19. Luangchosiri, C,Thakkinstian, A,Chitphuk, S,Stitchantrakul, W,Petraksa, S,Sobhonslidsuk, A(2015).A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury.BMC Complement Altern Med,15(1),334.
  20. Lynch, T,Price, A(2007).The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.Am Fam Physician,76,391-396.
  21. Mershiba, SD,Dassprakash, MV,Saraswathy, SD(2013).Protective effect of naringenin on hepatic and renal dysfunction and oxidative stress in arsenic intoxicated rats.Mol Biol Rep,40(5),3681-3691.
  22. Miglani, S,Patyar, RR,Patyar, S,Reshi, MR(2016).Effect of goat milk on hepatotoxicity induced by antitubercular drugs in rats.J Food Drug Anal,24(4),716-721.
  23. Misra, HP,Fridovich, I(1972).The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase.J Biol Chem,247(10),3170-3175.
  24. Ozkaya, A,Sahin, Z,Dag, U,Ozkaraca, M(2016).Effects of naringenin on oxidative stress and histopathological changes in the liver of lead acetate administered rats.J Biochem Mol Toxicol,30(5),243-248.
  25. Ramappa, V,Aithal, GP(2013).Hepatotoxicity related to anti-tuberculosis drugs: mechanisms and management.J Clin Exp Hepatol,3(1),37-49.
  26. Rao, V,Kiran, SD,Rohini, P,Bhagyasree, P(2017).Flavonoid: a review on naringenin.J Pharmacogn Phytochem,6(5),2778-2783.
  27. Raza, SS,Khan, MM,Ahmad, A(2013).Neuroprotective effect of naringenin is mediated through suppression of NF-κB signaling pathway in experimental stroke.Neuroscience,230,157-171.
  28. Renugadevi, J,Prabu, SM(2010).Cadmium-induced hepatotoxicity in rats and the protective effect of naringenin.Exp Toxicol Pathol,62(2),171-181.
  29. Renugadevi, J,Prabu, SM(2009).Naringenin protects against cadmium-induced oxidative renal dysfunction in rats.Toxicology,256(1-2),128-134.
  30. Roberts, JC,Francetic, DJ(1993).The importance of sample preparation and storage in glutathione analysis.Anal Biochem,211(2),183-187.
  31. Saad, EI,El-Gowilly, SM,Sherhaa, MO,Bistawroos, AE(2010).Role of oxidative stress and nitric oxide in the protective effects of a-lipoic acid and aminoguanidine against isoniazid-rifampicin-induced hepatotoxicity in rats.Food Chem Toxicol,48(7),1869-1875.
  32. Sharma, SK,KrishnaMurti, C(1968).Production of lipid peroxides by brain.J Neurochem,15(2),147-149.
  33. Sodhi, CP,Rana, SV,Mehta, SK(1996).Study of oxidative stress in isoniazidinduced hepatic injury in young rats with and without protein-energy malnutrition.J Biochem Toxicol,11(3),139-146.
  34. Thapa, BR,Walia, A(2007).Liver function tests and their interpretation.Indian J Pediatr,74(7),663-671.
  35. Wali, AF,Avula, B,Ali, Z(2015).Antioxidant, hepatoprotective potential and chemical profiling of propolis ethanolic extract from Kashmir Himalaya region using UHPLC-DAD-QToF-MS.BioMed Res Int,2015,393462.
  36. Wang, J,Yang, Z,Lin, L,Zhao, Z,Liu, Z,Liu, X(2012).Protective effect of naringenin against lead-induced oxidative stress in rats.Biol Trace Elem Res.,146(3),354-359.
  37. World Health Organization(2016).Global Tuberculosis Report.Geneva:World Health Organization.
  38. Yilma, AN,Singh, SR,Morici, L,Dennis, VA(2013).Flavonoid naringenin: a potential immunomodulator for Chlamydia trachomatis inflammation.Mediat Inflamm,2013,102457.